Citadel Advisors’s Innospec IOSP Stock Holding History
Bought
Maintained
Sold
Other funds holding IOSP
Citadel Advisors's IOSP Position: Q2 2026 in Review
Citadel Advisors reduced its Innospec (IOSP) stake by 55% in Q2 2026, selling an estimated $9.68M and leaving 98,549 shares worth $8.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3932.
Citadel Advisors first reported a position in IOSP in Q2 2013 and has held it in 48 quarters since. The position peaked at $16.1M in Q1 2026. 282 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.
- Citadel Advisors held 98,549 shares of Innospec worth $8.02M as of Q2 2026.
- Citadel Advisors sold 122,334 Innospec shares in Q2 2026, an estimated $9.68M.
- Innospec made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #3932 holding.
- Citadel Advisors first reported a position in Innospec in Q2 2013 and has held it in 48 quarters since.
- Citadel Advisors's Innospec position peaked at $16.1M in Q1 2026.
- 282 funds tracked by Wall St. Rank held Innospec as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.